Efficacy and safety of pimobendan in canine heart failure caused by myxomatous mitral valve disease

R dogs had a higher overall score and thus may have had more advanced disease than P dogs at baseline (P = 0.04). These results should be interpreted cautiously but such a high odds ratio warrants further investigation.